Harvard cost-utility league tables published

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.302, 2001-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness League Tables: Valuable Guidance for Decision Makers?

By Mauskopf J.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 991-1000

Adis International

Access to resources Recommend Favorite

Cost-benefit or cost-utility analysis?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Discounting in Cost-Utility Analysis of Healthcare Interventions: Reassessing Current Practice

By Cohen B.J.

PharmacoEconomics, Vol. 21, Iss. 2, 2003-01 ,pp. : 75-87

Adis International

Access to resources Recommend Favorite

30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement

By Neumann Peter J. Fang Chi-Hui Cohen Joshua T.

PharmacoEconomics, Vol. 27, Iss. 10, 2009-10 ,pp. : 861-872

Adis International

Access to resources Recommend Favorite

Methods for Measuring Temporary Health States for Cost-Utility Analyses

By Wright Davene R. Wittenberg Eve Swan J. Shannon Miksad Rebecca A. Prosser Lisa A.

PharmacoEconomics, Vol. 27, Iss. 9, 2009-09 ,pp. : 713-723

Adis International

Access to resources Recommend Favorite